Supplementary Materials for Financial Statements For the Year Ended March 31, 2023

May 12, 2023

Yakult Honsha Co., Ltd.

Public Relations Department

Investor Relations Department

URLhttps://www.yakult.co.jp/company/ir/

Contents

Consolidated

Page

1 Major Increases ( Decreases ) in Consolidated Balance Sheet

・・・

1

2 Major Increases ( Decreases ) in Consolidated Statement of Income

・・・

2

3 Performance Overview

・・・

3

-

4

4 Segment Information

・・・

5

-

12

5 Overview of Overseas Companies

・・・

13

-

14

Non-Consolidated

1 Major Increases ( Decreases ) in Non-consolidated Balance Sheet

・・・

15

Major Increases ( Decreases ) in Non-consolidated Statement of

2 Income

・・・

16

3 Performance Overview

・・・

17

4 Breakdown of Sales

・・・

18

-

20

5 Breakdown of Selling, General and Administrative Expenses

・・・

20

6 Retirement benefit expneses

・・・

20

7 Head Office Employees

・・・

21

8 Yakult Sales Company

・・・

21

9 Sales Personnel by Department

・・・

21

Reference

1 New Drug Development Pipeline etc.

・・・

22

2 Situation of Yakult Group ( Production Facilities )

・・・

23

3 Overseas Dairy Products sales ( Preliminary figure )

・・・

24

4 Environmental Response

・・・

25

About a numeric display of this material

1.Unit of money: Less than one million yen is rounded down.

2.Quantity results: Less than 1000 is rounded off.

3.Year on year percentage: The second place is rounded off after the decimal point.

Consolidated

1 Major Increases ( Decreases ) in Consolidated Balance Sheet

( Millions of yen )

As of Mar. 31

As of Mar. 31

Increase

Primary reason for change

2022

2023

( Decrease )

Total Assets

672,855

749,419

76,563

Current assets

Cash and deposits

202,941

241,185

38,243

Increase in Yakult Honsha and domestic subsidiaries

Increase in overseas subsidiaries (FX impact)

Notes and accounts receivable - trade Inventories

Others

Non-current assets

Property, plant and equipment

Buildings and structures, net Machinery, equipment and vehicles, net

Others, net

Intangible assets Investments and other assets

Investment securities Shares of subsidiaries and associates

Deferred tax assets Others

Total Liabilities

Current liabilities

Notes and accounts payable - trade

Short-term loans payable Others

Non-current liabilities

Long-term loans payable Net defined benefit liability Others

Total Net Assets

Shareholders' equity

Accumulated other comprehensive income

Non-controlling interests

52,581

60,139

7,558

30,649

36,703

6,054

14,226

16,166

1,940

84,139

93,771

9,631

52,964

62,508

9,543

74,052

68,843

(5,209)

5,386

5,570

183

67,628

66,000

(1,628)

73,044

79,673

6,629

3,822

4,052

229

11,418

14,805

3,386

187,920

203,922

16,002

26,039

28,958

2,918

10,239

49,047

38,808

53,001

69,639

16,637

60,298

14,559

(45,739)

4,280

4,279

(0)

34,059

37,438

3,378

484,935

545,496

60,561

454,169

475,006

20,837

(8,101)

23,652

31,753

38,867

46,837

7,970

Transfer from long-term loans payable

Transfer to short-term loans payable

Increase in foreign currency translation adjustments

- 1 -

2 Major Increases ( Decreases ) in Consolidated Statement of Income

( Millions of yen% )

FY2021

FY2022

Increase ( Decrease )

Primary reason for change

ForecastsRevised *

( 2021.4 ~ 2022.3 ) ( 2022.4 ~ 2023.3 )

Amount

Ratio

( 2022.4 ~

2023.3 )

Net sales

415,116

483,071

67,954

16.4

481,000

( Net sales by business segments )

Food and beverages ( Japan )

203,293

240,455

37,162

18.3

Increase in sales of dairy

products

Food and beverages ( Overseas )

185,000

215,109

30,108

16.3

FX impact +29,777

Pharmaceuticals

16,992

12,763

(4,229)

(24.9)

Others

19,473

25,445

5,972

30.7

Adjustments

(9,644)

(10,703)

(1,058)

11.0

Cost of sales

166,699

194,593

27,893

16.7

Gross profit

248,416

288,477

40,061

16.1

Gross profit margin

59.8

59.7

(0.1)

Selling, general and administrative expenses

195,213

222,409

27,195

13.9

Selling expenses

92,187

103,313

11,125

General and administrative expenses

103,026

119,096

16,070

Operating profit

53,202

66,068

12,866

24.2

64,000

Operating profit margin

12.8

13.7

0.9

( Operating profit by business segments )

Food and beverages ( Japan )

28,243

47,443

19,200

68.0

Food and beverages ( Overseas )

37,986

34,802

(3,184)

(8.4) FX impact +5,372

Pharmaceuticals

2,634

(192)

(2,826)

Others

(745)

1,242

1,988

Adjustments

(14,916)

(17,228)

(2,311)

15.5

{ include corporate expenses }

{ (9,446) }

{ (10,933) }

{ (1,486) }

15.7

Non-operating incomes

16,768

14,250

(2,518)

(15.0)

Interest income

3,305

6,036

2,730

Dividend income

1,919

1,970

51

Share of profit of entities accounted for using

6,432

2,638

(3,793)

equity method

Foreign exchange gain

2,417

427

(1,989)

Others

2,693

3,176

483

Non-operating expenses

1,420

2,347

926

65.2

Interest expenses

680

666

(14)

Others

740

1,681

941

Ordinary profit

68,549

77,970

9,421

13.7

FX impact +6,388

79,000

Ratio of ordinary profit to net sales

16.5

16.1

(0.4)

Extraordinary income

4,279

4,248

(30)

(0.7)

Extraordinary losses

3,349

3,690

340

10.2

Profit before income taxes

69,479

78,529

9,050

13.0

Income taxes

20,197

22,636

2,439

Profit

49,281

55,892

6,610

13.4

Profit attributable to non-controlling interests

4,364

5,251

887

20.3

Profit attributable to owners of parent

44,917

50,641

5,723

12.7

FX impact +4,357

50,000

Ratio of profit attributable to owners of

10.8

10.5

(0.3)

parent to net sales

  • Revised Forecasts announced on November 11, 2022

- 2 -

3 Performance Overview

( 1 ) Breakdown of Statement of Income

Fiscal year ended March 31, 2022

Fiscal year ended March 31, 2023

Performance

Year on year

Performance

Year on year

Net sales

415,116

107.6

483,071

116.4

Operating profit

53,202

121.8

66,068

124.2

Ordinary profit

68,549

119.0

77,970

113.7

to owners of parent

44,917

114.4

50,641

112.7

( 2 ) Ratios of Consolidated to Non-consolidated Results

Fiscal year ended March 31, 2022

Fiscal year ended March 31, 2023

Performance

Performance

Net sales

2.65

2.73

Operating profit

4.10

2.89

Ordinary profit

1.88

1.59

Profit attributable

1.44

1.24

to owners of parent

( 3 ) Share of profit of entities accounted for using equity method

Fiscal year ended March 31, 2022

Fiscal year ended March 31, 2023

Performance

Year on year

Performance

Year on year

Share of profit of

entities accounted for

6,432

164.5

2,638

41.0

using equity method

  • Millions of yen. % )
    Fiscal year ending March 31, 2024

Forecast

Year on year

531,000 109.9

75,500 114.3

91,000 116.7

58,500 115.5

( Times )

Fiscal year ending March 31, 2024

Forecast

2.78

2.75

1.73

1.38

  • Millions of yen. % )
    Fiscal year ending March 31, 2024

Forecast

Year on year

3,500 132.7

( 4 ) Major Items in selling, general and administrative expenses

( Millions of yen. % )

Fiscal year ended March 31, 2022

Fiscal year ended March 31, 2023

Fiscal year ending March 31, 2024

Performance

Year on year

Performance

Year on year

Forecast

Year on year

Advertising expenses

17,459

101.9

18,148

103.9

-

-

Promotion expenses

7,085

98.0

8,011

113.1

-

-

Sales commission

28,357

111.3

31,280

110.3

-

-

Freightage expenses

13,378

91.3

15,339

114.7

-

-

Salaries and allowance

47,354

109.4

55,453

117.1

-

-

Depreciation

4,563

100.9

4,589

100.6

-

-

development expenses

8,617

102.0

9,338

108.4

-

-

- 3 -

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Yakult Honsha Co. Ltd. published this content on 12 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 May 2023 05:32:13 UTC.